Rende, Italy

Francesco Lucchesini

This inventor holds 1 USPTO granted patent. Top assignee: Consiglio Nazionale Delle Ricerche. Active years: 1989.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Francesco Lucchesini: Innovator in Selective Inhibitors

Introduction

Francesco Lucchesini is a notable inventor based in Rende, Italy. He has made significant contributions to the field of chemistry, particularly in the development of selective inhibitors of benzylaminoxidases. His work has implications for various applications in medicinal chemistry and pharmacology.

Latest Patents

Lucchesini holds a patent for selective inhibitors of benzylaminoxidases. This patent describes inhibitors consisting of compounds with a specific general formula, which includes various functional groups. The innovation focuses on the selective inhibition of benzylaminoxidases while minimizing effects on other enzymes, showcasing Lucchesini's expertise in chemical synthesis and enzyme inhibition.

Career Highlights

Francesco Lucchesini is affiliated with the National Research Council of Italy (Consiglio Nazionale Delle Ricerche). His role in this esteemed institution allows him to engage in advanced research and development projects. His work has contributed to the understanding of enzyme mechanisms and the design of targeted inhibitors.

Collaborations

Lucchesini has collaborated with notable colleagues such as Vincenzo Bertini and Angela De Munno. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in their respective fields.

Conclusion

Francesco Lucchesini's contributions to the field of selective inhibitors highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to influence the landscape of medicinal chemistry and enzyme research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…